• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NXSTAGE MEDICAL, INC. DIALYSATE SACK WITH CONCENTRATE (SAK-302); DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NXSTAGE MEDICAL, INC. DIALYSATE SACK WITH CONCENTRATE (SAK-302); DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) Back to Search Results
Lot Number 11279186
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Low Blood Pressure/ Hypotension (1914); Itching Sensation (1943); Rash (2033); Dizziness (2194)
Event Date 02/15/2023
Event Type  Injury  
Event Description
Describe event, problem, or product use error: this was the patient's first and only exposure to nxstage hemodialysis.Patient had previously received a regular course of dialysis on fresenius 2008t dialysis system.Within one minute of starting dialysis, patient reported "my back itches".The nurse ended dialysis treatment after 3 minutes for significant reduction in blood pressure.Patient initially answered negative for symptoms of hypotension "i feel fine except for the itching".After dialysis termination was complete, patient reported dizziness, and developed hives.In approximately 5 minutes, the patient had improved to normal blood pressure, with residual dizziness and hives had faded.Lab specimens collected were not to diagnose a condition or monitor treatment, but rather assess the dialysis for contaminants and organisms.All pre-treatment tests and checks of the dialysis formula (automatic conductivity test in range & chlorine/chloramine levels zero) and circuit pressures passed.Post-incident lab specimens were collected from the dialysis purification system and final dialysis formula that the patient was exposed to.All lab results were in acceptable ranges for electrolytes, colony count, and endotoxin.Patient had no known allergies prior to this incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIALYSATE SACK WITH CONCENTRATE (SAK-302)
Type of Device
DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
Manufacturer (Section D)
NXSTAGE MEDICAL, INC.
MDR Report Key16505279
MDR Text Key311013181
Report NumberMW5115559
Device Sequence Number1
Product Code KPO
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Nurse
Type of Report Initial
Report Date 03/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/07/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date11/15/2023
Device Lot Number11279186
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Patient Age69 YR
Patient SexMale
Patient Weight97 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-